Literature DB >> 20536447

Thymosin beta4 and its posttranslational modifications.

E Hannappel1.   

Abstract

Thymosin beta(4) as well as the other members of the beta-thymosin family are important G-actin sequestering peptides. The chemical properties, the biosynthesis, and posttranslational modifications (PTMs) of these peptides are discussed. During biosynthesis of thymosin beta(4) the initiator methionine is removed and the N-terminus is acetylated. Research on proteomics revealed several acetylated lysine residues and two phosphorylated threonine residues. The enormous number of phosphorylable and acetylable sites in the human proteome raises the question about the biological significance of these PTMs in the context of beta-thymosins. Presently, this question cannot be answered because neither the concentration of these modified beta-thymosins in cells is known nor the consequences of the modifications on the biological function(s) of beta-thymosins have been studied yet. Thymosin beta(4) is also posttranslationally modified by transglutaminase forming covalent bonds with other molecules. Prolyl oligopeptidase generates ac-SDKP from thymosin beta(4). The concentration of C-terminal peptide fragments of thymosin beta(4) is elevated in the blood of patients with rheumatoid arthritis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20536447     DOI: 10.1111/j.1749-6632.2010.05485.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  12 in total

1.  Alzheimer disease periventricular white matter lesions exhibit specific proteomic profile alterations.

Authors:  Eduardo M Castaño; Chera L Maarouf; Terence Wu; Maria Celeste Leal; Charisse M Whiteside; Lih-Fen Lue; Tyler A Kokjohn; Marwan N Sabbagh; Thomas G Beach; Alex E Roher
Journal:  Neurochem Int       Date:  2012-12-08       Impact factor: 3.921

Review 2.  The biological significance of angiotensin-converting enzyme inhibition to combat kidney fibrosis.

Authors:  Takako Nagai; Kyoko Nitta; Megumi Kanasaki; Daisuke Koya; Keizo Kanasaki
Journal:  Clin Exp Nephrol       Date:  2014-07-01       Impact factor: 2.801

Review 3.  Tβ4-Ac-SDKP pathway: Any relevance for the cardiovascular system?

Authors:  Kamal M Kassem; Sonal Vaid; Hongmei Peng; Sarah Sarkar; Nour-Eddine Rhaleb
Journal:  Can J Physiol Pharmacol       Date:  2019-03-09       Impact factor: 2.273

4.  Prolyl oligopeptidase induces angiogenesis both in vitro and in vivo in a novel regulatory manner.

Authors:  T T Myöhänen; J Tenorio-Laranga; B Jokinen; R Vázquez-Sánchez; M J Moreno-Baylach; J A García-Horsman; P T Männistö
Journal:  Br J Pharmacol       Date:  2011-08       Impact factor: 8.739

5.  Identification of thymosins β4 and β 10 in paediatric craniopharyngioma cystic fluid.

Authors:  Claudia Desiderio; Claudia Martelli; Diana Valeria Rossetti; Concezio Di Rocco; Luca D'Angelo; Massimo Caldarelli; Gianpiero Tamburrini; Federica Iavarone; Massimo Castagnola; Irene Messana; Tiziana Cabras; Gavino Faa
Journal:  Childs Nerv Syst       Date:  2013-03-17       Impact factor: 1.475

6.  Effects of thymosin β4 on a rat model of severe acute pancreatitis.

Authors:  Xiaobo He; Jia Yu; Wenyi Guo; Teng Zuo; Qiao Shi; Kailiang Zhao; Weixing Wang
Journal:  Exp Ther Med       Date:  2015-10-14       Impact factor: 2.447

7.  Recombinant Human Thymosin Beta-4 Protects against Mouse Coronavirus Infection.

Authors:  Rui Yu; Yunyun Mao; Kai Li; Yanfang Zhai; Yue Zhang; Shuling Liu; Yuemei Gao; Zhengshan Chen; Yanhong Liu; Ting Fang; Mengsu Zhao; Ruihua Li; Junjie Xu; Wei Chen
Journal:  Mediators Inflamm       Date:  2021-04-21       Impact factor: 4.711

8.  Elevation of the antifibrotic peptide N-acetyl-seryl-aspartyl-lysyl-proline: a blood pressure-independent beneficial effect of angiotensin I-converting enzyme inhibitors.

Authors:  Megumi Kanasaki; Takako Nagai; Munehiro Kitada; Daisuke Koya; Keizo Kanasaki
Journal:  Fibrogenesis Tissue Repair       Date:  2011-11-30

Review 9.  N-acetyl-seryl-aspartyl-lysyl-proline: a valuable endogenous anti-fibrotic peptide for combating kidney fibrosis in diabetes.

Authors:  Keizo Kanasaki; Takako Nagai; Kyoko Nitta; Munehiro Kitada; Daisuke Koya
Journal:  Front Pharmacol       Date:  2014-04-14       Impact factor: 5.810

10.  β-thymosins and hemocyte homeostasis in a crustacean.

Authors:  Netnapa Saelee; Chadanat Noonin; Benjamas Nupan; Kingkamon Junkunlo; Amornrat Phongdara; Xionghui Lin; Kenneth Söderhäll; Irene Söderhäll
Journal:  PLoS One       Date:  2013-04-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.